Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00000230 |
Recruitment Status :
Completed
First Posted : September 21, 1999
Last Update Posted : May 6, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Opioid-Related Disorders | Drug: Buprenorphine | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 0 participants |
Primary Purpose: | Treatment |
Official Title: | Buprenorphine Detoxification With Two Types of Treatment. BBD III |
Study Start Date : | January 1995 |

- Drug use
- Retention
- Weeks abstinent
- Weeks continuous abstinence
- Overall treatment outcome

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000230
United States, Vermont | |
Treatment Research Center | |
Burlington, Vermont, United States, 05401 |
Principal Investigator: | Warren Bickel, Ph.D. | University of Vermont |
ClinicalTrials.gov Identifier: | NCT00000230 |
Other Study ID Numbers: |
NIDA-06969-12 R01DA006969 ( U.S. NIH Grant/Contract ) R01-06969-12 |
First Posted: | September 21, 1999 Key Record Dates |
Last Update Posted: | May 6, 2016 |
Last Verified: | August 1996 |
Opioid-Related Disorders Narcotic-Related Disorders Substance-Related Disorders Chemically-Induced Disorders Mental Disorders Buprenorphine Analgesics, Opioid |
Narcotics Central Nervous System Depressants Physiological Effects of Drugs Analgesics Sensory System Agents Peripheral Nervous System Agents Narcotic Antagonists |